Lee's Pharmaceutical Holdings Limited (HKG:0950)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.210
+0.075 (6.61%)
Sep 18, 2026, 3:57 PM HKT

HKG:0950 Balance Sheet

Millions HKD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
364.39349.9216.85171189.3277.53
Cash & Short-Term Investments
364.39349.9216.85171189.3277.53
Cash Growth
20.03%61.36%26.81%-9.67%-31.79%-33.05%
Accounts Receivable
215.7190.71161.184.59111.28168.32
Other Receivables
113.410.36-45.41-23.34
Receivables
329.12191.07161.1130111.28191.66
Inventory
420.99364.43287.51298.11249.22331.39
Prepaid Expenses
-131.7550.17.5853.8859.7
Other Current Assets
91.97132.1569.0349.9447.95103.04
Total Current Assets
1,2061,169784.59656.63651.63963.32
Property, Plant & Equipment
364.57384.73400.59443.37540.67688.27
Long-Term Investments
503.26548.74285.21699.45554.751,043
Goodwill
3.93.94.374.373.93.9
Other Intangible Assets
1,394305.05311.63282.36293.75302.26
Long-Term Deferred Tax Assets
9.4411.918.110.27.5815.42
Long-Term Deferred Charges
-1,040823.39794.29729.74620.26
Total Assets
3,4823,4642,6182,8912,7823,637

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
250.24174.63141.9774.15101.362.6
Short-Term Debt
-10.342.3225.39-12.26
Current Portion of Long-Term Debt
162.68203.76107.6496.7376.73150.28
Current Portion of Leases
7.389.17.87.456.8312.64
Current Income Taxes Payable
10.222.248.776.083.060.13
Other Current Liabilities
703.91730.16462.76439.02462.18684.67
Total Current Liabilities
1,1341,130771.25648.82650.1922.58
Long-Term Debt
73.881.5763.9170.6477.3684.09
Long-Term Leases
5.985.545.633.932.577.87
Pension & Post-Retirement Benefits
141.71135.71122.79110.196.23111.97
Long-Term Deferred Tax Liabilities
117.09106.3284.2373.4373.979.23
Other Long-Term Liabilities
62.92104.321.1523.1539.3440
Total Liabilities
1,5361,5641,069930.07939.51,246

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
29.4429.4429.4429.4429.4429.44
Additional Paid-In Capital
720.09720.09720.09720.09720.09720.09
Retained Earnings
3,7973,7113,6423,5613,5443,511
Comprehensive Income & Other
-2,421-2,415-2,739-2,271-2,369-1,796
Total Common Equity
2,1252,0461,6522,0391,9242,465
Minority Interest
-179.1-145.58-102.89-78.36-81.58-73.42
Shareholders' Equity
1,9461,9001,5491,9611,8432,391
Total Liabilities & Equity
3,4823,4642,6182,8912,7823,637

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
249.84310.27227.3204.14163.49267.14
Net Cash (Debt)
114.5539.63-10.45-33.1425.8110.39
Net Cash Growth
91.08%---148.36%-95.97%
Net Cash Per Share
0.190.07-0.02-0.060.040.02
Filing Date Shares Outstanding
588.84588.84588.84588.84588.84588.84
Total Common Shares Outstanding
588.84588.84588.84588.84588.84588.84
Working Capital
72.0539.0913.337.811.5340.74
Book Value Per Share
3.613.472.813.463.274.19
Tangible Book Value
726.911,7371,3361,7521,6262,158
Tangible Book Value Per Share
1.232.952.272.982.763.67
Buildings
-229.88217.54225.35232.29259.65
Machinery
-671.81571.77561.37548.42572.66
Construction In Progress
-27.912.4424.7838.6252.57
Leasehold Improvements
-66.6971.4675.6975.7581